High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence
2021 ◽
Vol 116
(9)
◽
pp. 1896-1904
2010 ◽
Vol 52
(4)
◽
pp. 501-507
◽
2016 ◽
Vol 23
(Suppl 1)
◽
pp. A145.2-A146